1. 2013 ACC/AHA cholesterol treatment guidelines
Sanjay Rajagopalan 
Journal of Indian College of Cardiology 
Volume 5, Pages S15-S20 (March 2015)
DOI: /j.jicc
Copyright © Terms and Conditions

2. Fig. 1
Effects on major coronary events, strokes, coronary revascularization procedures, and major vascular events per 1·0 mmol/L reduction in LDL cholesterol at different levels of risk. MVE = major vascular event. RR = rate ratio. CI = confidence interval.
Source: Cholesterol Treatment Trialists′ (CTT) Collaborators. Lancet Aug 11; 380(9841): 581–590
Journal of Indian College of Cardiology 2015 5, S15-S20DOI: ( /j.jicc )
Copyright © Terms and Conditions

3. Fig. 2 Major recommendations for statin therapy for ASCVD prevention.
Journal of Indian College of Cardiology 2015 5, S15-S20DOI: ( /j.jicc )
Copyright © Terms and Conditions

4. Fig. 3
Primary prevention in those without diabetes/ASCVD and LDL-C 70–189 mg/dl. *FHX-Family History, CRP-C reactive protein, CAC-coronary artery calcium scores, TLC-Therapeutic lifestyle changes.
Journal of Indian College of Cardiology 2015 5, S15-S20DOI: ( /j.jicc )
Copyright © Terms and Conditions

5. Fig. 4
Percent of U.S. adults who would be eligible for statin therapy for primary prevention, according to set of guidelines and age group.
Source: Michael J. Pencina et al. N Engl J Med 2014;370:
Journal of Indian College of Cardiology 2015 5, S15-S20DOI: ( /j.jicc )
Copyright © Terms and Conditions

6. Fig. 5 Improved risk stratification with coronary calcium scoring.
Source: Madhavan MV, et al. J Am Coll Cardiol May 6;63(17):
Journal of Indian College of Cardiology 2015 5, S15-S20DOI: ( /j.jicc )
Copyright © Terms and Conditions